Unverified80% confidenceFactTime unknown
双环醇（如百赛诺）为国产创新药，对多种肝损伤有临床降酶数据，停药需在医生指导下逐渐减量以减少反跳
1
Sources
80%
Confidence
Long-term
Relevance
-
First Seen
Sources
Related Entities
Related Claims
Unverified双环醇（百赛诺）是国产原研药，对慢性肝炎和药物性肝损伤的降ALT有较好循证证据，停药后可能出现转氨酶反跳，需逐渐减量而非骤停92% similarUnverified该药定位为急性期/重度肝损伤的住院注射用药；如果是慢性轻度肝损伤或脂肪肝的长期调理，应优先考虑口服剂型（如多烯磷脂酰胆碱胶囊、水飞蓟素片等）78% similarUnverified使用需严格按剂量并注意用药间隔，过量对乙酰氨基酚存在肝损伤风险，勿与含相同成分的其他药同服77% similarUnverified西替利嗪、氯雷他定主要经肝脏代谢，与酮康唑、红霉素等CYP酶抑制剂合用可能升高血药浓度；非索非那定几乎不经肝代谢，多重用药者（尤其老年多病）优先选非索非那定降低相互作用风险76% similarUnverified长期服药（如抗结核药、他汀类）或饮酒者应选含ALP（碱性磷酸酶）和总胆汁酸的进阶套装，这两项对药物性肝损伤和胆道问题更敏感76% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/451971API
curl https://kongchang.com/api/v1/knowledge/claims/451971MCP
get_claim(id=451971)